Kiran Mazumdar Shaw's Journey: From Rejection to Revolutionizing Healthcare
Thank God' she did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder Kiran Mazumdar Shaw's inspiring journey
The Economic TimesImage: The Economic Times
Dr. Devi Shetty shared an inspiring life lesson about Kiran Mazumdar Shaw, who turned her rejection from medical school into a transformative journey. Instead of becoming a doctor, she founded Biocon, revolutionizing access to affordable medicine in India and impacting millions of lives.
- 01Kiran Mazumdar Shaw's rejection from medical school led her to a different path in healthcare.
- 02She founded Biocon, significantly improving access to affordable medicine for millions.
- 03Dr. Devi Shetty emphasized the broader societal impact of her decision.
- 04Shaw's journey illustrates how setbacks can lead to unexpected opportunities.
- 05She continues to lead Biocon while preparing her successor, Claire Mazumdar.
Advertisement
In-Article Ad
At an event in 2015 at the Indian Institute of Management Bangalore, Dr. Devi Shetty, founder of Narayana Health, recounted the inspiring journey of Kiran Mazumdar Shaw, who faced rejection from medical school. Instead of giving up, Shaw redirected her ambitions towards creating affordable healthcare solutions, ultimately founding Biocon, a major player in the biotechnology sector. Dr. Shetty highlighted that this decision allowed her to impact millions of lives, particularly in providing affordable insulin for diabetes patients. He remarked that her journey exemplifies how personal setbacks can lead to significant societal change, suggesting that the country should be grateful for her unconventional path. Kiran Mazumdar Shaw, a first-generation entrepreneur, has over four decades of experience in biotechnology and has been recognized globally for her contributions. With an estimated net worth of โน30,000 crore (around $3.6 billion USD), she continues to lead Biocon while preparing her successor, Claire Mazumdar, to ensure continuity in her vision.
Advertisement
In-Article Ad
Kiran Mazumdar Shaw's work has significantly improved access to essential medicines, benefiting millions of patients in India and beyond.
Advertisement
In-Article Ad
Reader Poll
Do you believe setbacks can lead to greater opportunities?
Connecting to poll...
More about Biocon
Biocon Shares Rise Following Kiran Mazumdar-Shaw's Niece Named as Successor
The Economic Times โข May 5, 2026
Kiran Mazumdar Shaw's Journey: From Rejection to Revolutionizing Biotechnology
The Economic Times โข May 5, 2026
Claire Mazumdar Positioned as Future Leader of Biocon Amid Transition
The Economic Times โข May 5, 2026
Read the original article
Visit the source for the complete story.

